Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape
Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief
Novartis CEO Warns: Trump Tariffs Could Ignite Drug Price Surge and Stifle Innovation
Novartis Plots Strategic Price Adjustments in US as Trump's MFN Deadline Looms
The Future of Vision: Could Eye Drops Really Replace Your Reading Glasses?
India Delivers Major Blow to Novartis: Blockbuster Heart Drug Entresto Patent Revoked
Novartis Forges Monumental US$5.7 Billion Alliance with Monte Rosa Therapeutics to Revolutionize Drug Discovery